Table 2

Change of BMD in patients treated with pamidronate iv or oral bisphosphonates

Oral bisphosphonates n = 31

Pamidronate n = 30

BMD Start G/cm2 (SD)

BMD after 4.2 years treatment g/cm2 (SD)

Change of BMD % (range)

BMD Start g/cm2 (SD)

BMD after 4.3 years treatment g/cm2 (SD)

Change of BMD % (range)

Spine

0.800

(0.171)

0.856

(0.139)

8.3 (55.3)*

0.782

(0.092)

0.830

(0.112)

6.1 (33.8)*

Hip

0.714

(0.127)

0.724

(0.136)

1.1 (33.6) §

0.739

(0.126)

0.749

(0.116)

1.4 (27.8)‡

There is a significant increase in BMD of the spine in both groups (* p < 0.001) and a non significant increase in the hip in both groups. (§ p = 0.358 and ‡ p = 0.252)

Eekman et al. BMC Musculoskeletal Disorders 2009 10:86   doi:10.1186/1471-2474-10-86